Korsuva

Korsuva Warnings and Precautions

• CNS effects: Dizziness, somnolence, and mental status changes have been reported; patients should be monitored, particularly at treatment initiation.
• Falls: Increased risk of falls has been observed; caution is advised, especially in elderly patients.
• Gait disturbance: Patients should be monitored for changes in gait or coordination after dosing.
• Not for use outside hemodialysis setting: Korsuva must only be administered as part of the hemodialysis procedure by trained healthcare staff.

How to Access Korsuva in India: A 6-Step Process

Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.

Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.

Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.

Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.

Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant conditions to maintain product integrity.

Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.

Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.

Documentation & Availability

What documents are required to import Korsuva to India?

Korsuva (difelikefalin) injection may be imported in the patient's name only, by patients or government hospitals, in line with India's import regulations for unapproved medicines. The following documentation is required:

• A valid prescription from a qualified nephrologist
• The patient's diagnostic reports confirming chronic kidney disease and hemodialysis-associated pruritus
• Patient ID proof (issued by the Government of India)

How is the order confirmed?

The order is confirmed only after receipt and verification of a valid prescription from the doctor and, if applicable, an import permit.

Is Korsuva available in India?

Korsuva (difelikefalin injection) is a prescription medicine that legally requires a doctor's prescription to be dispensed. As of current publicly available information, Korsuva is not commercially marketed in India.

However, dialysis centers and patients in India can legally access Korsuva through the Named Patient Program (NPP) — an import provision that allows access to medicines approved in other countries but not yet marketed in India, under a doctor's prescription and proper regulatory documentation.

Korsuva received US FDA approval in August 2021 for moderate to severe pruritus associated with chronic kidney disease in hemodialysis patients, ensuring full transparency throughout the process.

Korsuva can be made available to patients, doctors, and hospitals across major cities in India, including Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Gorakhpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and others.

Sourcing & Delivery of Korsuva

Korsuva is sourced directly from authorized channels in the country of origin and shipped to India under GDP-compliant logistics to preserve product integrity from dispatch to delivery.

• Storage maintained at 15°C to 30°C throughout transit, protected from freezing
• Real-time shipment tracking and delivery updates
• Delivery coordinated directly with the patient, family, or treating dialysis center

Availability of Korsuva Across Major Cities in India

Named Patient Program supports access to Korsuva for hemodialysis patients with pruritus across major cities in India, coordinating documentation, sourcing, and delivery with treating nephrologists and dialysis centers.

Mumbai

Patients in Mumbai can access Korsuva through NPP with support from treating nephrologists at the city's leading dialysis centers.

Delhi

In Delhi, NPP coordinates with hospitals and dialysis centers to facilitate timely access to Korsuva.

Bangalore

Bangalore's nephrology and dialysis centers work with NPP to support patients requiring Korsuva.

Chennai

Patients in Chennai can access Korsuva through NPP, with coordination between treating doctors and the program's regulatory and logistics team.

Hyderabad

Hyderabad's nephrology centers support diagnosis and access coordination for Korsuva through NPP.

Kolkata

NPP facilitates access to Korsuva for patients in Kolkata under the guidance of treating nephrologists.

Pune

Patients in Pune can access Korsuva through NPP with prescription-based coordination and delivery support.

Ahmedabad

NPP supports access to Korsuva for patients in Ahmedabad, working directly with treating specialists.

Kochi

Patients in Kochi and across Kerala can access Korsuva through NPP's regulated import pathway.

Chandigarh

NPP coordinates access to Korsuva for patients in Chandigarh and the surrounding region.

Jaipur

Patients in Jaipur can access Korsuva through NPP with support from treating nephrologists.

Lucknow

NPP facilitates access to Korsuva for patients in Lucknow and across Uttar Pradesh.

Bhubaneswar

Patients in Bhubaneswar can access Korsuva through NPP's coordinated import and delivery process.

Guwahati

NPP supports access to Korsuva for patients in Guwahati and across the Northeast region.

NPP also supports access for patients in other Indian cities not listed above — contact the team to check availability and timelines for your location.